Why the buyside?
Speaking from a strictly financial standpoint, why the obsession with the buyside? It seems like even middle-tier MDs are able to rake in at least as much if not significantly more than your average PE partner at a MM/LMM firm (though I could be wrong). Additionally, with the best IB talent going to the buyside year after year, that makes competition much fiercer than for those who stay in IB.
Anyone have thoughts on this?